Abstract:Objective: The purpose of this study was to investigate the specific alterations in gut microbiome and serum metabolome and their interactions in patients with polycystic ovary syndrome (PCOS). Methods: The stool samples from 32 PCOS patients and 18 healthy controls underwent the intestinal microbiome analysis using shotgun metagenomics sequencing approach. Serum metabolome was analyzed by ultrahigh performance liquid chromatography quadrupole time-of-flight mass spectrometry. An integrative network by combining metagenomics and metabolomics datasets was constructed to explore the possible interactions between gut microbiota and circulating metabolites in PCOS, which was further assessed by fecal microbiota transplantation (FMT) in a rat trial. Results: Fecal metagenomics identified 64 microbial strains significantly differing between PCOS and healthy subjects, half of which were enriched in patients. These changed species showed an ability to perturb host metabolic homeostasis (including insulin resistance and fatty acid metabolism) and inflammatory levels (such as PI3K/Akt/mTOR signaling pathways) by expressing sterol regulatory element-binding transcription factor-1, serine/threonine-protein kinase mTOR, and 3-oxoacyl-[acyl-cattier-protein] synthase III, possibly suggesting the potential mechanisms of gut microbiota underlying PCOS. By integrating multi-omics datasets, the panel comprising seven strains ( Achromobacter xylosoxidans , Pseudomonas sp. M1, Aquitalea pelogenes , Porphyrobacter sp. HL-46, Vibrio fortis , Leisingera sp. ANG-Vp, and Sinorhizobium meliloti ) and three metabolites [ganglioside GM3 (d18:0/16:0), ceramide (d16:2/22:0), and 3Z,6Z,9Z-pentacosatriene] showed the highest predictivity of PCOS (AUC: 1.0) with sensitivity of 0.97 and specificity of 1.0. Moreover, the intestinal microbiome modifications by FMT were demonstrated to regulate PCOS phenotypes including metabolic variables and reproductive hormones. Conclusion: Our findings revealed key microbial and metabolite features and their interactions underlying PCOS by integrating multi-omics approaches, which may provide novel insights into discovering clinical diagnostic biomarkers and developing efficient therapeutic strategies for PCOS.

Association of SOGPI in mediating the effect of Phosphatidylcholine on polycystic Ovary Syndrome

To Assess the Association between Glucose Metabolism and Ectopic Lipid Content in Different Clinical Classifications of PCOS

Characterization of the gut microbiota in polycystic ovary syndrome with dyslipidemia

Dysbiosis of Gut Microbiota Associated with Clinical Parameters in Polycystic Ovary Syndrome

Gut microbiome in PCOS associates to serum metabolomics: a cross-sectional study

Aberrant Expression and DNA Methylation of Lipid Metabolism Genes in PCOS: a New Insight into Its Pathogenesis.

Integrated lipid metabolomics and proteomics analysis reveal the pathogenesis of polycystic ovary syndrome

Dyslipidemia involvement in the development of polycystic ovary syndrome

Metabonomics Reveals Plasma Metabolic Changes and Inflammatory Marker in Polycystic Ovary Syndrome Patients

Differential Lipidomic Characteristics of Children Born to Women with Polycystic Ovary Syndrome

Insulin resistance, autophagy and apoptosis in patients with polycystic ovary syndrome: Association with PI3K signaling pathway

Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis

Comprehensive Assessment of the STIMs and Orais Expression in Polycystic Ovary Syndrome

Multi-omics analyses reveal the specific changes in gut metagenome and serum metabolome of patients with polycystic ovary syndrome

Gut microbiota–bile acid–interleukin-22 axis orchestrates polycystic ovary syndrome

Correlation between serum thyroid stimulating hormone level and glycolipid metabolism in patients with polycystic ovary syndrome

Serum fatty acid profiles associated with metabolic risk in women with polycystic ovary syndrome

Comparison of nutritional supplements in improving glycolipid metabolism and endocrine function in polycystic ovary syndrome: a systematic review and network meta-analysis

The gut microbial composition in polycystic ovary syndrome with hyperandrogenemia and its association with steroid hormones

Serum metabolomics analysis of patients with polycystic ovary syndrome by mass spectrometry

Cross-talk between oxidative stress and lipid metabolism regulators reveals molecular clusters and immunological characterization in polycystic ovarian syndrome